Cargando…

SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study

SIMPLE SUMMARY: Prostate-specific antigen and digital rectal examination, used to guide prostate biopsy, often result in overdiagnosis of indolent prostate cancer (PCa) while missing clinically significant PCa (csPCa). The aim of this study was to evaluate the diagnostic accuracy of SelectMDx and it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maggi, Martina, Del Giudice, Francesco, Falagario, Ugo G., Cocci, Andrea, Russo, Giorgio Ivan, Di Mauro, Marina, Sepe, Giuseppe Salvatore, Galasso, Fabio, Leonardi, Rosario, Iacona, Gabriele, Carroll, Peter R., Cooperberg, Matthew R., Porreca, Angelo, Ferro, Matteo, Lucarelli, Giuseppe, Terracciano, Daniela, Cormio, Luigi, Carrieri, Giuseppe, De Berardinis, Ettore, Sciarra, Alessandro, Busetto, Gian Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122883/ https://www.ncbi.nlm.nih.gov/pubmed/33922626 http://dx.doi.org/10.3390/cancers13092047

Ejemplares similares

Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2021)

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer
por: Visser, Wieke C. H., et al.
Publicado: (2022)

A SelectMDx/magnetic resonance imaging‐based nomogram to diagnose prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2022)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021)

Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
por: Bruno, Salvatore M., et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
por: Maggi, Martina, et al.
Publicado: (2021)

Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Radiomics in prostate cancer: an up-to-date review
por: Ferro, Matteo, et al.
Publicado: (2022)

Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men
por: Hendriks, Rianne J., et al.
Publicado: (2021)

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center
por: Annese, Pasquale, et al.
Publicado: (2021)

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2018)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation
por: Selvaggio, Oscar, et al.
Publicado: (2023)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2022)

Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study
por: Porreca, Angelo, et al.
Publicado: (2020)

Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging
por: de Cobelli, Ottavio, et al.
Publicado: (2015)

Male esthetic genital surgery: recommendations and gaps to be filled
por: Bettocchi, Carlo, et al.
Publicado: (2022)

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
por: Salciccia, Stefano, et al.
Publicado: (2021)

Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer
por: Cormio, Antonella, et al.
Publicado: (2021)

Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion
por: Selvaggio, Oscar, et al.
Publicado: (2023)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
por: Ferro, Matteo, et al.
Publicado: (2017)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
por: Barone, Biagio, et al.
Publicado: (2023)

Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Long-Term Results of Combined Tunica Albuginea Plication and Penile Prosthesis Implantation for Severe Penile Curvature and Erectile Dysfunction
por: Cormio, Luigi, et al.
Publicado: (2014)

Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern
por: Sanguedolce, Francesca, et al.
Publicado: (2021)

Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
por: Calò, Beppe, et al.
Publicado: (2021)

Modulation of complement activation by pentraxin-3 in prostate cancer
por: Stallone, Giovanni, et al.
Publicado: (2020)

Hem-O-Lok clip: a neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy
por: Cormio, Luigi, et al.
Publicado: (2014)

Prostatic Leiomyoma – Multiparametric Prostate MRI Features
por: Vergauwen, Ortwin, et al.
Publicado: (2018)

Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study
por: Cormio, Luigi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_talhnim0i07uhj49rthkfj276j